Publications
Development of ABS-101: A potential best-in-class anti-TL1A antibody for the treatment of IBD
Science Blogs
Absci at the Senate AI Forum
Using generative AI to unlock HIV
Novel Target Discovery via Reverse Immunology
Therapeutic Antibody Design – The AI-assisted Future Of Lead Optimization
